These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 17197923)

  • 1. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D; Povýsil C; Svatosová J; Dundr P
    Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
    Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
    Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
    Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
    Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
    Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
    Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
    Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
    Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
    Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Tsuji S; Hisaoka M; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M; Nakamura T
    Am J Pathol; 1998 Dec; 153(6):1807-12. PubMed ID: 9846971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.
    Saito T; Oda Y; Sakamoto A; Tamiya S; Kinukawa N; Hayashi K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2000 Nov; 192(3):342-50. PubMed ID: 11054718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.